Oncology Institute Of Southern Switzerland

This study aims to create a tool that can better predict which patients with follicular lymphoma will remain progression-free two years after their initial treatment. Researchers will analyze existing tumor samples and medical records from 370 patients to identify patterns linked…

This study aimed to learn how a drug called ruxolitinib changes immune cells inside prostate tumors. Men scheduled for prostate cancer surgery would have taken the drug for four weeks before their operation. Researchers planned to analyze tumor and blood samples to see how the dr…